International differences in cancer survival rates: the role of new drug launches
Download
Download
Download
Full text for this resource is not available from the Research Repository.
Export
Lichtenberg, Frank R (2009) International differences in cancer survival rates: the role of new drug launches. International Journal of Healthcare Technology and Management, 10 (3). pp. 138-155. ISSN 1368-2156
Abstract
We investigate the effect of availability of new drugs on survival from 17 types of cancer in 38 countries, controlling for all determinants of cancer survival that are invariant across cancer types within a given country, and that are invariant across countries for a given cancer type. We find that an increase in the number of available drugs is associated with an increase in both the one-year and the five-year survival rate. Also, the probability that a cancer drug has been launched in a country depends on the incidence of cancer cases eligible for treatment by that drug in that country.
| Item type | Article |
| URI | https://vuir.vu.edu.au/id/eprint/4421 |
| Subjects | Historical > FOR Classification > 1117 Public Health and Health Services Historical > FOR Classification > 1402 Applied Economics Historical > SEO Classification > 9204 Public Health (excl. Specific Population Health) Historical > Faculty/School/Research Centre/Department > Centre for Strategic Economic Studies (CSES) |
| Keywords | ResPubID17923, cancer survival rates, longevity, pharmaceuticals, innovation, drug launches, new drugs, neoplasm, international differences, cancer drugs |
| Citations in Scopus | 5 - View on Scopus |
| Download/View statistics | View download statistics for this item |
CORE (COnnecting REpositories)